According to Roche's latest financial reports the company has $39.56 B in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2023-12-31 | $39.56 B | 14.16% |
2022-12-31 | $34.65 B | 11.71% |
2021-12-31 | $31.02 B | -31.24% |
2020-12-31 | $45.11 B | 21.84% |
2019-12-31 | $37.02 B | 19.94% |
2018-12-31 | $30.87 B | 3.63% |
2017-12-31 | $29.78 B | 14.94% |
2016-12-31 | $25.91 B | 9.9% |
2015-12-31 | $23.58 B | 8.14% |
2014-12-31 | $21.80 B | -8.91% |
2013-12-31 | $23.94 B | 30.44% |
2012-12-31 | $18.35 B | 18.7% |
2011-12-31 | $15.46 B | 23.91% |
2010-12-31 | $12.47 B | 37.1% |
2009-12-31 | $9.10 B | -82.36% |
2008-12-31 | $51.60 B | 9.31% |
2007-12-31 | $47.21 B | 22.69% |
2006-12-31 | $38.47 B | 26.08% |
2005-12-31 | $30.51 B | 4.58% |
2004-12-31 | $29.18 B | 23.74% |
2003-12-31 | $23.58 B | -17.09% |
2002-12-31 | $28.44 B | -23.9% |
2001-12-31 | $37.37 B |
Company | Net assets | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $70.02 B | 76.98% | ๐บ๐ธ USA |
Novartis NVS | $39.75 B | 0.49% | ๐จ๐ญ Switzerland |
Pfizer PFE | $89.28 B | 125.69% | ๐บ๐ธ USA |
Abbott Laboratories ABT | $38.82 B | -1.86% | ๐บ๐ธ USA |
Amgen AMGN | $6.23 B | -84.25% | ๐บ๐ธ USA |
Sanofi SNY | $82.20 B | 107.78% | ๐ซ๐ท France |
Becton Dickinson BDX | $25.33 B | -35.97% | ๐บ๐ธ USA |
Merck MRK | $37.63 B | -4.87% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $16.71 B | -57.74% | ๐ฌ๐ง UK |